Wencong Zhang, Jia Chen, Wenjin Sun, Nana Xie, Fangbing Tian, Wenyuan Zhang et al. HBsAg seroreversion after pegylated interferon alpha induced HBsAg seroclearance in patients with chronic hepatitis B: a real-world cohort study. // BMC Infectious Diseases. – 2026. – DOI: 10.1186/s12879-026-13989-x. – URL: https://doi.org/10.1186/s12879-026-13989-x
Wencong Zhang, Jia Chen, Wenjin Sun, Nana Xie, Fangbing Tian, Wenyuan Zhang, Yan Wang, Qiurong Ruan, & Jianxin Song (2026). HBsAg seroreversion after pegylated interferon alpha induced HBsAg seroclearance in patients with chronic hepatitis B: a real-world cohort study. BMC Infectious Diseases. https://doi.org/10.1186/s12879-026-13989-x
Wencong Zhang, et al. “HBsAg seroreversion after pegylated interferon alpha induced HBsAg seroclearance in patients with chronic hepatitis B: a real-world cohort study.” BMC Infectious Diseases, 2026. doi:10.1186/s12879-026-13989-x.
@article{Zhang2026,
title = {HBsAg seroreversion after pegylated interferon alpha induced HBsAg seroclearance in patients with chronic hepatitis B: a real-world cohort study},
author = {Zhang, Wencong and Chen, Jia and Sun, Wenjin and Xie, Nana and Tian, Fangbing and Zhang, Wenyuan and Wang, Yan and Ruan, Qiurong and Song, Jianxin},
journal = {BMC Infectious Diseases},
year = {2026},
doi = {10.1186/s12879-026-13989-x},
url = {https://doi.org/10.1186/s12879-026-13989-x}
}